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1. Introduction 
Polymorphonuclear leukocytes respond chemotac- 
tically, in vitro, to a variety of compounds including 
denaturated proteins [l], factors derived from com- 
plement [2], bacterial products [3] and synthetic 
peptides, the most potent being the peptide formyl- 
methionyl-leucyl~phenylalanine (f-Met-Leu-Phe) 
[4,5]. In addition f-Met-Leu-Phe induces granule 
enzyme secretion and superoxide production when 
added with cytochalasin B to rabbit neutrophils in 
suspension [4.6] and aggregates these cells [7]. There 
is evidence that all these functions result from the 
interaction of the peptide with a common membrane 
receptor [4,668] which has been demonstrated, by 
direct binding studies, to exist on the cell surface of 
rabbit [9] and human neutrophils [lo]. 
If rabbit peritoneal neutrophils were incubated with 
high concentrations of a chemoattractant derived from 
complement, then washed, the cells showed a dimin- 
ished chemotactic responsiveness towards the same 
stimulus [ 111. This phenomenon had been termed 
‘chemotactic deactivation’ [ 111 and although it has 
been noted with other chemotactic factors, including 
f-Met-Leu-Phe [ 121 it has not received a satisfactory 
explanation. However, deactivation of neutrophils is 
not restricted to chemotaxis [ 131. If rabbit peritoneal 
neutrophils are incubated with f-Met-Leu-Phe, then 
washed before being rechallenged with the same pep- 
tide and cytochalasin B, the cells show a decreased 
secretory responsiveness. This deactivation might be 
related to a loss of binding sites for the peptide [ 131. 
Since in many other systems (reviewed [14]) deac- 
tivation (or desensitization or refractoriness) has been 
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shown to be effectively related to a loss of binding 
sites on the cells for the effector, we have decided to 
see if this was true also for chemotactic deactivation. 
Here we show, using human peripheral blood 
neutrophils, that there is a time and dose-dependent 
decrease in the chemotactic responsiveness of these 
cells towards f-Met-Leu-Phe when they are prein- 
cubated with the same peptide then washed. However, 
these changes in chemotactic responsiveness are neither 
accompanied by a loss of binding sites for this peptide 
nor by a difference in the affinity for its receptor. 
2. Materials and methods 
f-Met-Leu-Phe was purchased from UCB, 
Bruxelles. f-Met -Leu- [3H] Phe was prepared by 
J.L.M. by catalytic dehalogenation of the peptide 
f-Met-Leu-Phe(I)-OH (Bachem. Switz.) and was 
shown to be 100% pure by thin-layer chromatography 
and amino acid analysis. Its specific activity was 
24 Ci/mmol and it was biologically indistinguishable 
from unlabelled f-Met -Leu-Phe. 
Polymorphonuclear neutrophils were obtained 
from heparinized peripheral blood of human volunteers 
by method in [lo] and were 298% pure. 
Neutrophils were washed twice and resuspended in 
solution A (Hanks’ balanced salt solution buffered 
with 50 mM Hepes (pH 7.2) containing 2% bovine 
serum albumin) at 1.5 X lo6 cells/ml and incubated, 
at 37”C, in solution A alone or in solution A containing 
different concentrations of the chemotactic peptide. 
At the end of the incubation period, the cells were 
collected by centrifugation (3.50 X g for 10 min) and 
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resuspended in 40 ml solution A. After 10 min at 
37”C, the sedimentation and resuspension were 
repeated. After an additional 10 min at 37”C, the cells 
were again centrifuged for 10 min at 350 X g and 
resuspended in solution A. Final concentrations at 
the end of the washings were lo-12 X lo6 cells/ml. 
Aliquots of this suspension of washed cells were used 
to study f-Met-Leu-[3H]Phe binding or chemotaxis 
towards fresh f-Met-Leu-Phe. 
Chemotaxis was measured by using ‘r Cr-labelled 
neutrophils as in [ 151, in a modified Boyden chamber 
(Celloplex, Basel) with 2 cellulose nitrate filters of 
poresize 3 pm and 5 pm on top of each other. The 
SICr-labelled neutrophils at 4 X lo6 cells/ml were 
placed in the upper compartment of the chemotactic 
chamber. The chemotactic peptide was diluted, from 
a stock solution at 10e3 M in dimethylsulfoxide, in 
solution A and used in the lower compartment of the 
chamber at final cont. 10m8 M. The chambers were 
incubated for 3 h at 37°C in 100Y0 humidity and 
5% COZ. At the end of the incubation the lower filters 
were removed, rinsed and counted in a y counter 
(Kontron Electronics CC 4000). Results are expressed 
as cpm in lower filter/total cpm put in the upper 
compartment of the chamber. 
All binding studies were performed in solution A 
at 22°C in plastic microcentrifuge tubes (Beckman) 
in 0.2 ml final vol. Neutrophils were incubated with 
increasing concentrations of f-Met-Leu-[3H]-Phe 
for 30 min. The incubation was started by addition of 
cells and terminated by dilution with 1 ml ice-cold 
Hanks’ solution followed by centrifugation (10 s at 
12 000 rev./min). The supernatant was discarded by 
aspiration and the cell pellets were then washed 
rapidly with 1 ml ice-cold Hanks’ solution and sepa- 
rated again by 10 s centrifugation. The cell pellets 
were then dissolved in aqueous sodium dodecyl 
sulfate (250 ~1, O.lYo) and transfered to counting vials 
containing 10 ml Instagel. Radioactivity was measured 
in a liquid scintillation spectrophotometer (Kontron 
Electronics SL 3000). Non-specific binding was defined 
as the amount of binding not inhibited by 50 PM 
unlabelled f-Met-Leu-Phe and was usually lo-15% 
of the total counts bound. Specific binding was 
defined as the total amount of f-Met-Leu-[3H]Phe 
bound minus the non-specific binding. 
3. Results 
Table 1 presents the results of experiments in which 
various suspensions of neutrophils were incubated at 
37°C with f-Met-Leu-Phe or in solution A alone. 
After washing, the cells were tested for chemotaxis 
towards the same fresh peptide. There is a time- and 
dose-dependent inhibition of chemotaxis when the 
cells are preincubated with f-Met-Leu-Phe at >10m8 M. 
After preincubation and washing, we also deter- 
mined the peptide receptor concentration/cell by 
incubating the washed cells at 22”C, for 30 min (a 
time shown to be necessary to reach equilibrium) with 
increasing concentrations of f-Met-Leu-[3H]Phe 
(fig.1). It can be seen that f-Met-Leu-[3H]Phe bind- 
ing to cells that had been preincubated with IO-’ M 
f-Met-Leu-Phe for 1 h, or with 10e6 M peptide for 
Table 1 
Effect of preincubation of neutrophils with f-Met-Leu-Phe on locomotion towards the same peptide 
Cells migrating 
towards 
Preincuba- No Cells preincubated with f-Met-Leu-Phe 
tion (min) peptide 
lo-*’ M 10“ M lo-’ M lo+ M lo-’ M 
(% cells migrating in the lower filter) 
No peptide 1.45 _ 
f-Met-Leu-Phe lo-’ M 
0 - 
8.66 
No peptide 1.51 1.61 1.63 
f-Met-Leu-Phe lo-’ M 5 7.60 7.83 8.27 
No peptide 
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1.63 1.58 1.51 
f-Met-Leu-Phe lo-* M 8.33 7.44 7.72 
No peptide 1.93 1.55 1.93 
f-Met-Leu-Phe lo-’ M 30 8.79 7.32 5.86 
No peptide 1.52 1.61 1.34 
f-Met-Leu-Phe 10m8 M 60 7.43 7.60 2.15 
Each figure is the mean of 4 different determinations done in duplicate 
1.58 1.55 1.53 
5.78 4.34 2.12 
1.43 1.33 1.61 
3.29 1.66 1.91 
1.46 1.55 1.74 
2.9 1.71 1.93 
1.55 1.37 1.58 
2.01 1.43 1.65 
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Fig.1. (A) Binding of f-Met-Leu-[3H]Phe to neutrophils as 
a function of concentration of f-Met-Leu-[‘HIPhe. f-Met- 
Leu- [ 3 H] Phe at the indicated concentrations was incubated 
with human neutrophils for 30 mm at 22°C and specific bind- 
ing was measured (o-0). Cells which had been incubated 
for 1 hat 37°C m solution A alone, (o-o) Cells which had 
been incubated for 1 h at 37°C in the presence of f-Met- 
Leu-Phe IO-* M and then washed. (-.-A) Cells which had 
been incubated for 30 min at 37°C in the presence of f-Met- 
Leu-Phe 10m6 M and then washed. Each value shown repre- 
sents the mean of 3 determinations done in duplicate. (B) The 
data are plotted according to Scatchard’s analysis. 
30 min, was identical to that of cells that had not been 
exposed to the peptide (fig.lA). Analysis of the 
Scatchard’s plots (fig.1 B) indicates that there is 
neither decrease in the effective concentration of 
receptors, nor alteration in affinity. With either set of 
cells, the equilibrium dissociation constant (Kd) was 
2.2 X lo-’ M. At saturation, the 1.8 X lo6 cells 
present in the incubation mixture are capable of 
binding 118 fmol f-Met-Leu-[3H]Phe. This value 
corresponds to -40 000 sites/cell is 20 times higher 
than that in [lo]. This may be because the receptor 
sites were not fully saturated for the peptide on the 
neutrophils in fig.3 and fig.4A of [lo]. Using rabbit 
peritoneal neutrophils and the radiolabelled analogue 
[3H]f-NorLeu-Leu-Phe, [9] Kd and R,,, of 
1.5 X 10e9 M and 102 000 sites/cell, respectively 
were found; in [15] Kd = 3 X lo-’ M. 
In further set of experiments we tested the ability 
of our washing procedure to reverse the binding of 
f-Met-Leu-[3H]Phe.Cells(15 X lO’j)wereincubated, 
in duplicate, with f-Met-Leu-[3H]Phe 4 X lo-’ M 
in 1 ml solution A. After 1 h at 37”C, two 100 ~1 
aliquots were removed, washed with ice-cold Hanks’ 
solution and their radioactivity determined. The 
800 ~1 left were diluted with 40 ml solution A at 
37°C and washed twice as in section 2. At the end of 
the washing procedure. the cell pellet was resuspended 
in 1 ml solution A at 32°C. Two 100 /_d aliquots were 
immediately removed, washed with ice-cold Hanks’ 
solution and their radioactivity measured. The remain- 
ing cells were separated in three 190 ~1 fractions on 
which the total and non-specific binding of fresh 
f-Met-Leu-[3H]Phe, 4 X 10-s M, were measured as 
in section 2. Cells preincubated in solution A alone 
were treated under the same conditions. The results 
of these experiments are presented in table 3. It can 
Table 2 
Reversal of f-Met-Leu- [ ‘H] Phe binding by the 
washing procedure 
____ 
Cell treatment cpm/2 X lo6 cells 
Cells preincubated with f-Met-Leu- 
[3H]Phe 4 X lo-* Mat 37°C for 1 h, 
washed at 0°C and counted 1834 
Cells preincubated with f-Met-Leu- 
[‘HIPhe 4 X 10m8 M at 37°C for 1 h, 
washed twice at 37°C and counted 590 
Cells preincubated with f-Met -Leu - 
[3H]Phe 4 X lo-* Mat 37°C for 1 h, 
washed twice at 37°C and rechallenged 
with fresh f-Met-Leu-[3H] Phe 
4 x low8 M for 30 mm at 22°C 1920 
Cells preincubated and washed at 
37°C as above and rechallenged with 
fresh f-Met-Leu-[‘HIPhe 4 X 10e8 M 
and f-Met-Leu-Phe 5 X 10e5 M for 
30 mm at 22°C 680 
Cells preincubated in solution A alone 
for 1 h at 37”C, washed twice at 37°C 
and challenged with f-Met-Leu-[3H]Phe 
4 x lo-’ M for 30 mm at 22°C 1433 
Cells preincubated in solution A alone 
for 1 h at 37”C, washed twice at 37°C 
and challenged with f-Met-Leu-[3H]Phe 
4 X IO-* M and f-Met-Leu-Phe 
5 X 10m5 M for 30 mm at 22°C 199 
Each value is the mean of 2 different determinations done in 
duplicate. 1433 cpm/2 X lo6 cells represent 80 fmol peptide 
bound on the cells 
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be seen that cells preincubated either in solution A Leu-Phe [ 121 was that deactivation is the functional 
alone or in presence of f-Met-Leu-[3H]Phe can bind manifestation of an unorganized chemotactic factor- 
the same amount of fresh radiolabelled peptide cor- sensitive microtubule assembly and not the bockade 
roborating the results of fig.1. It can be seen also that of available receptors. However, levamisole and the cal- 
cells preincubated with f-Met-Leu- 13H]Phe and then 
washed thoroughly at 37°C keep an amount of radio- 
cium ionophore A23 187, if present during the prein- 
cubation of neutrophils with f-Met-Leu-Phe, could 
activity slightly higher than the non-specific binding. prevent the inhibition of chemotaxis [ 191. Since 
This result and our data (not shown) on the kinetics neither drug interferes with the binding of f-Met- 
of binding of f-Met-Leu-[3H]Phe on human neutro- Leu- t3H] Phe (our data not shown) it is possible that 
phils suggest hat a certain amount of peptide is inte- cyclic nucleotides or calcium, or both, may be involved 
riorized after its association with the cells. in the molecular mechanism of neutrophil deactivation, 
4. Discussion 
We have demonstrated that human peripheral blood 
neutrophils preincubated with the synthetic chemo- 
tactic peptide f-Met-Leu-Phe and then washed lose, 
in a time and dose-dependent fashion, their ability to 
respond chemotactically to the same peptide. This 
deactivation of chemotaxis is already manifest after 
5 min preincubation of cells with peptide at >10e8 M. 
In conclusion, these data show, by direct binding 
experiments with f-Met-Leu-[3H]Phe, that the 
chemotactic deactivation of human neutrophils, 
induced by preincubation of the cells with the pep- 
tide, is not due to a loss of binding sites for the chemo- 
attractant. Whatever the molecular mechanism for this 
deactivation of chemotaxis, it certainly involves a step 
beyond the binding of the peptide to its membrane 
receptor. Work is in progress in our laboratory to 
investigate this problem. 
Usingradiolabelled f-Met-Leu-Phe we have shown 
that our washing procedure is able to displace all the 
peptide that was originally bound to the cells during 
the preincubation period. Thus neutrophils which had 
been preincubated with f-Met-Leu--Phe at GO-’ M 
and then washed have the same total binding capacity 
for f-Met-Leu- [3H] Phe than do cells preincubated 
in buffer alone. 
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Our results are in accord with those in [ 161 (while 
this manuscript was in preparation) who also found 
that human neutrophils preincubated with high con- 
centrations of f-Met-Leu-Phe are chemotactically 
deactivated. They also found that these deactivated 
cells do not respond chemotactically to a gradient of 
complement-derived factors. Since these chemoat- 
tractants (essentially C5a and C3a [ 171) are totally 
unrelated to f-Met-Leu-Phe and have different 
specific receptors on the neutrophils [ 181 it is highly 
improbable that a loss of binding sites for f-Met- 
Leu-Phe would impair neutrophil chemotaxis 
towards the complement-derived factors. The expla- 
nation for chemotactic deactivation of human neutro- 
phils claimed in [ 161 was that high concentrations of 
f-Met -Leu-Phe render the cells hyperadhesive leading 
to profoundly diminished directed and random migra- 
tion. 
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